Ras activity late in G1 phase required for p27(kip1) downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblast

Molecular and Cellular Biology

Volumn 17, Issue 9, 1997, Pages 5348-5358

  Takuwa, Noriko ^a   Takuwa, Yoh ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN 3T3; DNA SYNTHESIS; DOWN REGULATION; FIBROBLAST CULTURE; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030740210     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.9.5348     Document Type: Article

References (62)

1. Aprelikova, O., Y. Xiong, and E. T. Liu. 1995. Both p16 and p21 families of cyclin-dependent kinases (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270: 18195-18197.
2. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
3. Brown, E. J., M. W. Alberts, T. B. Shin, K. Ichikawa, C. T. Keith, W. S. Lane, and S. L. Schneiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369:756-758.
4. Brunn, G. J., J. Williams, C. Sabers, G. Wiederrecht, J. C. Lawrence, Jr., and R. T. Abraham. 1996. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15:5256-5267.
5. Cai, H., J. Szeberényi, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10:5314-5323.
6. Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880.
7. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of N1H3T3 cells. Cell 77:841-852.
8. Cross, F. R. 1990. Cell cycle arrest caused by CLN gene deficiency in Saccharomyces cerevisiae resembles START-I arrest and is independent of the mating-pheromone signalling pathway. Mol. Cell. Biol. 10:6482-6490.
9. Davis, R. J. 1993. The mitogen-aclivated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553-14556.
10. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
11. 1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14:5441-5449.
12. Gibbs, J. B., M. S. Marshall, E. M. Scolonick, R. A. F. Dixon, and U. S. Vogel. 1990. Modulation of guanine-nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating proteins (GAP). J. Biol Chem. 265:20437-20442.
13. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417.
14. Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:3995-4005.
15. Hamada, K., N. Takuwa, W. Zhou, M. Kumada, and Y. Takuwa. 1996. Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochim. Biophys. Acta 1310:149-156.
16. Hartwell, L. H., J. Culotti, J. R. Pringle, and B. J. Reid. 1974. Genetic control of the cell division cycle in yeast. Science 183:46-51.
17. Kip1 accumulation during the cell cycle. Science 271:1861-1864.
18. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
19. Hill, C. S., and R. Treisman. 1995. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
20. Jakobisiak, M., S. Bruno, J. S. Skierski, and S. Darzynkiewkz. 1991. Cell cycle-specific effects of lovastatin. Proc. Natl. Acad. Sci. USA 88:3628-3632.
21. Janknecht, R., W. H. Ernst, V. Pingoud, and A. Nordheim. 1993. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12:5097-5104.
22. Kahan, C., K. Seuwen, S. Meloche, and J. Pouyssegur. 1992. Coordinate, hiphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. J. Biol. Chem. 267:13369-13375.
23. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
24. Kimura, K., S. Hattori, Y. Kabuyama, Y. Shizawa, K. Onodera, and Y. Fukui. 1994. Neurite outgrowth of PC 12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinases. J. Biol. Chem. 269: 18961-18967.
25. Leone, G., J. DeGregori, R. Sears. L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422-426.
26. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506.
27. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
28. Mitsui, H., N. Takuwa, K. Kurokawa, J. H. Exton, and Y. Takuwa. 1997. Dependence of activated Gα12-induced G1 to S phase cell cycle progression on both Ras/MAPK and Ras/Rac1/JNK cascades in NIH3T3 fibroblasts. J. Biol. Chem. 272:4904-4910.
29. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
30. Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH3T3 cells. Nature 313:241-243.
31. Nakafuku, M., T. Satoh, and Y. Kaziro. 1992. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras · GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem. 267:19448-19454.
32. Nasmyth, K. 1993. Control of the yeast cell cycle by the Cdc28 protein kinase. Curr. Opin. Cell. Biol. 5:166-179.
33. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
34. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
35. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. DelSal, V. Chan, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
36. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319-8323.
37. Pardee, A. B. 1974. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71:1286-1290.
38. Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen. 1997. Ras signalling linked to the cell cycle machinery by the retinoblastoma protein. Nature 386:177-181.
39. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
40. Richardson, H. E., C. Wittenberg, F. Cross, and S. I. Reed. 1989. An essential G1 function for cyclin-like proteins in yeast. Cell 59:1127-1133.
41. Kip1 by cDNA antisense suppresses quiescence (GO state) in fibroblasts. J. Biol. Chem. 271:18337-18341.
42. Roche, S., M. Koegl, and S. A. Courtneidge. 1994. The phosphatidylinositol 3-kinase α is required for DNA synthesis induced by some, but not all, growth factors. Proc. Natl. Acad. Sci. USA 91:9185-9189.
43. Rodriguez-Viciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. J. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-532.
44. ras GTP complex in Swiss mouse 3T3 cells. Proc. Natl. Acad. Sci. USA 87:5993-5997.
45. Satoh, T., M. Nakafuku, A. Miyajima, and Y. Kaziro. 1991. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3. and granulocyte/macrophage colony stimulating factor, but not from interleukin 4. Proc. Natl. Acad. Sci. USA 88:3314-3318.
46. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
47. Szeberényi, J., H. Cai, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10:5324-5332.
48. Takuwa, N., and Y. Takuwa. Unpublished data.
49. 2+ stores in cell cycle progression at the G1/S boundary in serum-stimulated human fibroblasts. FEBS Lett. 360:173-176.
50. 2+ influx in bombesin-induced mitogenesis in Swiss3T3 fibroblasts. J. Biol. Chem. 266:1403-1409.
51. 2+/calmodulin is involved in growth factor-induced retinoblastoma gene product phosphorylation in human vascular endothelial cells. FEBS Lett. 306:173-175.
52. 2+-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J. Biol. Chem. 268:138-145.
53. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell 78:67-74.
54. ras by G protein-coupled receptor agonists in fibroblasts. Proc. Natl. Acad. Sci. USA 90:1257-1261.
55. Warbe, P. H., P. Rodriguez, and J. Downward. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364:352-355.
56. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
57. Xing, J., D. D. Ginty, and M. E. Greenberg. 1996. Coupling of the Ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273:959-963.
58. Kip1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17:407-415.
59. Zhang, W., L. Grasso, C. D. McClain, A. M. Gambel, Y. Cha, S. Travail, A. B. Deisseroth, and W. E. Mercer. 1995. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55:668-674.
60. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364:308-313.
61. Zhou, W., N. Takuwa, M. Kumada, and Y. Takuwa. 1993. Protein kinase C-mediated bidirectional regulation of DNA synthesis. RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J. Biol. Chem. 268:23041-23048.
62. Zhou, W., N. Takuwa, M. Kumada, and Y. Takuwa. 1994. E2F1, B-myb and selective members of cyclin/CDK subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells. Biochem. Biophys. Res. Commun. 199:191-198.